Leerink analyst Andrew Berens reiterated an Outperform rating and $165.00 price target on Nuvalent (NASDAQ: NUVL).The analyst comments "We spoke ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE